We recently published
10 Stocks With Easy 20-40% Gains. Illumina, Inc. (NASDAQ:ILMN) is one of the last week's best-performing stocks.
Illumina rallied by 23.4 percent week-on-week after beating its earnings guidance in the third quarter of the year and projecting a lower revenue decline in the full fiscal 2025 period.
In an updated report, Illumina, Inc. (NASDAQ:ILMN) saw net income fall by 79 percent to $150 million from $705 million previously, as revenues ended flat at $1.08 billion.
“Illumina team delivered Q325 results that exceeded the high-end of our guidance range for revenue and earnings, driven by revenue acceleration in clinical, our largest market segment,” said CEO Jacob Thaysen.
“During the quarter, we returned to growth ex-China and are executing on our strategic pillars that support our long-range financial targets,” he added.
For fiscal year 2025, Illumina, Inc. (NASDAQ:ILMN) now expects revenues to decline by only 0.5 percent to 1.5 percent year-on-year, a revision of the upper end range of 2.5 percent previously.
Illumina, Inc. (NASDAQ:ILMN) is one of the leading genomics companies that engages in providing DNA sequencing and array-based technologies for life sciences, oncology, and reproductive health, among others.
While we acknowledge the potential of ILMN as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the
best short-term AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This article is originally published at
Insider Monkey.
